As a result, gene therapy efforts in BBS are concentrated on rescuing photoreceptor cells alone, frequently employing gene vectors containing photoreceptor-specific promoters such as rhodopsin to drive exogenous gene expression. Here, RHO is linked to Bardet-Biedl syndrome.